Global Blood Screening Market Overview:
Global Blood Screening Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2024-2035, Considering the Base Year As 2025.
Global Blood Screening Market Report 2026 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2024-2035, with base year as 2025. This research study of Blood Screening involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Blood Screening Market:
The Blood Screening Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Blood Screening Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Blood Screening Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Blood Screening market has been segmented into:
Reagents & Kits
Instruments
Software & Services
By Application, Blood Screening market has been segmented into:
Nucleic Acid Test (NAT)
Enzyme-Linked Immunosorbent Assay (ELISA)
Rapid Tests
Western Blot Assay
Next-Generation Sequencing (NGS
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Blood Screening market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Blood Screening market.
Top Key Players Covered in Blood Screening market are:
Abbott Laboratories
Beckman Coulter Inc.
Becton
Dickinson & Company
bioMerieux SA
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche AG
Grifols International SA
Ortho Clinical Diagnostics Inc.
Siemens Healthineers
Thermo Fisher Scientific Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Blood Screening Market Type
4.1 Blood Screening Market Snapshot and Growth Engine
4.2 Blood Screening Market Overview
4.3 Reagents & Kits
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.3.3 Reagents & Kits: Geographic Segmentation Analysis
4.4 Instruments
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.4.3 Instruments: Geographic Segmentation Analysis
4.5 Software & Services
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.5.3 Software & Services: Geographic Segmentation Analysis
Chapter 5: Blood Screening Market Application
5.1 Blood Screening Market Snapshot and Growth Engine
5.2 Blood Screening Market Overview
5.3 Nucleic Acid Test (NAT)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.3.3 Nucleic Acid Test (NAT): Geographic Segmentation Analysis
5.4 Enzyme-Linked Immunosorbent Assay (ELISA)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.4.3 Enzyme-Linked Immunosorbent Assay (ELISA): Geographic Segmentation Analysis
5.5 Rapid Tests
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.5.3 Rapid Tests: Geographic Segmentation Analysis
5.6 Western Blot Assay
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.6.3 Western Blot Assay: Geographic Segmentation Analysis
5.7 Next-Generation Sequencing (NGS
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.7.3 Next-Generation Sequencing (NGS: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Blood Screening Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES; BECKMAN COULTER
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; BECTON
6.4 DICKINSON & COMPANY; BIOMERIEUX SA; BIO-RAD LABORATORIES
6.5 INC.; F. HOFFMANN-LA ROCHE AG; GRIFOLS INTERNATIONAL SA; ORTHO CLINICAL DIAGNOSTICS
6.6 INC.; SIEMENS HEALTHINEERS; THERMO FISHER SCIENTIFIC
6.7 INC.
Chapter 7: Global Blood Screening Market By Region
7.1 Overview
7.2. North America Blood Screening Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Reagents & Kits
7.2.2.2 Instruments
7.2.2.3 Software & Services
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Nucleic Acid Test (NAT)
7.2.3.2 Enzyme-Linked Immunosorbent Assay (ELISA)
7.2.3.3 Rapid Tests
7.2.3.4 Western Blot Assay
7.2.3.5 Next-Generation Sequencing (NGS
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Blood Screening Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Reagents & Kits
7.3.2.2 Instruments
7.3.2.3 Software & Services
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Nucleic Acid Test (NAT)
7.3.3.2 Enzyme-Linked Immunosorbent Assay (ELISA)
7.3.3.3 Rapid Tests
7.3.3.4 Western Blot Assay
7.3.3.5 Next-Generation Sequencing (NGS
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Blood Screening Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Reagents & Kits
7.4.2.2 Instruments
7.4.2.3 Software & Services
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Nucleic Acid Test (NAT)
7.4.3.2 Enzyme-Linked Immunosorbent Assay (ELISA)
7.4.3.3 Rapid Tests
7.4.3.4 Western Blot Assay
7.4.3.5 Next-Generation Sequencing (NGS
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Blood Screening Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Reagents & Kits
7.5.2.2 Instruments
7.5.2.3 Software & Services
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Nucleic Acid Test (NAT)
7.5.3.2 Enzyme-Linked Immunosorbent Assay (ELISA)
7.5.3.3 Rapid Tests
7.5.3.4 Western Blot Assay
7.5.3.5 Next-Generation Sequencing (NGS
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Blood Screening Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Reagents & Kits
7.6.2.2 Instruments
7.6.2.3 Software & Services
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Nucleic Acid Test (NAT)
7.6.3.2 Enzyme-Linked Immunosorbent Assay (ELISA)
7.6.3.3 Rapid Tests
7.6.3.4 Western Blot Assay
7.6.3.5 Next-Generation Sequencing (NGS
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Blood Screening Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Reagents & Kits
7.7.2.2 Instruments
7.7.2.3 Software & Services
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Nucleic Acid Test (NAT)
7.7.3.2 Enzyme-Linked Immunosorbent Assay (ELISA)
7.7.3.3 Rapid Tests
7.7.3.4 Western Blot Assay
7.7.3.5 Next-Generation Sequencing (NGS
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Blood Screening Scope:
|
Report Data
|
Blood Screening Market
|
|
Blood Screening Market Size in 2025
|
USD XX million
|
|
Blood Screening CAGR 2025 - 2032
|
XX%
|
|
Blood Screening Base Year
|
2024
|
|
Blood Screening Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, Beckman Coulter Inc., Becton, Dickinson & Company, bioMerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Grifols International SA, Ortho Clinical Diagnostics Inc., Siemens Healthineers, Thermo Fisher Scientific Inc..
|
|
Key Segments
|
By Type
Reagents & Kits
Instruments
Software & Services
By Applications
Nucleic Acid Test (NAT)
Enzyme-Linked Immunosorbent Assay (ELISA)
Rapid Tests
Western Blot Assay
Next-Generation Sequencing (NGS
|
